Wells Fargo Lowers Salesforce Price Target

Table of Contents

Event Breakdown

Reasons Behind the Cut

Salesforce’s Recent Performance

Stock Market Impact

Analyst Consensus

Strategic AI Focus

Broader SaaS Context

Investor Implications

Future Outlook

Event Breakdown

Wells Fargo analyst Michael Turrin lowered the target on February 18, 2026, implying about 26.5% upside from recent closes around $185. The firm cited muted core growth and sector pressures, even as Salesforce’s Q3 FY26 results showed Agentforce ARR surging 330% YoY to over $500 million. This downgrade follows Salesforce’s December 2025 earnings beat, where revenue hit $10.26 billion (up 9.1% YoY), and EPS reached $3.25, exceeding estimates.​

Reasons Behind the Cut

Slower enterprise adoption of AI tools like Agentforce, despite 9,500+ paid deals and 3.2 trillion tokens processed, tempers optimism. Broader SaaS market fears of decelerating growth, high valuations, and macroeconomic headwinds contribute, with Salesforce stock down 40% over the past year to ~$185. Wells Fargo views Q3 upside as partly one-time from license revenue, with public sector performance measured.​

Salesforce’s Recent Performance

In Q3 FY26 (ended Oct 2025), Salesforce raised its FY26 revenue guidance to $41.45-41.55 billion (9-10% growth) and maintained a 34.1% non-GAAP margin. Agentforce and Data 360’s combined ARR neared $1.4 billion (114% YoY), with cRPO at $29.4 billion (11% up). The Informatica acquisition bolsters data unification, processing 32 trillion records.​​

Stock Market Impact

CRM shares traded around $185-187 post-downgrade, with the 50-day MA at $235 and the 200-day at $241, reflecting a sharp pullback from 1-year highs of $330. Trading volume spiked modestly, but the stock dipped 1.3% amid analyst actions. Market cap sits at ~$174 billion, with P/E at 24.8.

Analyst Consensus

Despite Wells Fargo’s cut, 53 firms rate Salesforce a moderate buy/outperform (avg. target $314-318, up 72% from $184). Recent trims include Mizuho ($340 to $280), UBS ($260 to $200), and Oppenheimer ($300 to $275), but bulls like Needham hold $400. The GF Value estimates show that CRM is significantly undervalued at $299.

Strategic AI Focus

Salesforce positions itself as the “#1 AI CRM” via Agentforce for autonomous agents, with 70% QoQ production accounts and 50% bookings from expansions. Over 18,500 deals since launch show an enterprise shift from pilots to scale. Data Cloud and platform growth (e.g., Slack up 19%) fuel the flywheel toward $60B+ revenue ambitions.​​

Broader SaaS Context

A “SaaS scare” grips the sector with growth slowdown fears, but Salesforce’s AI traction (e.g., UBS notes rising Agentforce checks) counters the trend. Insider activity mixes: Director David Blair bought $500K worth of shares at $259, while Parker Harris sold $31M at $235. Institutions hold 80%, with Vanguard/State Street adding positions.​

Investor Implications

The PT cut underscores near-term risks but doesn’t derail the long-term AI narrative. Watch Q4 FY26 guidance ($11.1-11.2B revenue, $3.02-3.04 EPS). At current levels, undervaluation per models like InvestingPro suggests a buy opportunity for AI believers. Risk-tolerant investors may eye dips, balancing SaaS volatility with Agentforce momentum.

Future Outlook

Salesforce targets 50%+ margins by FY30 via the Profitable Growth Framework, leveraging AI for sales efficiency. Partnerships (e.g., AcuityMD, Asymbl) expand the ecosystem. If Agentforce scales to offset core deceleration, it rebounds to $300+ avg. The targets are feasible; otherwise, range-bound trading persists.